Brian Van Tine, MD, Ph.D., associate professor of medical oncology, Washington University School of Medicine speaks about the ASCO 2021 Abstract – SPEARHEAD-1: A phase 2 trial of afamitresgene autoleucel (Formerly ADP-A2M4) in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma. Link to Abstract:https://meetinglibrary.asco.org/record/195713/abstract Backstory:Advertisement Single Between Content Advertisement Single Between Content Advertisement Single … Continue reading Brian Van Tine, MD @bvantine1 @WUSTLmed @WUSTL @Adaptimmune #ASCO21 #SPEARHEAD1 #Sarcoma #Cancer #Research SPEARHEAD-1: A Phase 2 Trial